Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway (Q39627892)
Jump to navigation
Jump to search
scientific article published on 24 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway |
scientific article published on 24 November 2010 |
Statements
1 reference
Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway (English)
1 reference
1 reference
1 reference
1 reference
Antonio Cuneo
1 reference
Elisabetta Melloni
1 reference
Raffaella Bosco
1 reference
Rebecca Voltan
1 reference
24 November 2010
1 reference
1 reference
Identifiers
1 reference